Adoption of Gla-100 in India and its Impact on Insulin Usage Patterns.

K D Modi,Sujeet Jha, Subodh Banzal, Biplab Bandopadhyay, G D Ramchandani, Sridevi Atluri, Radhika V Kumar, Sushil Kiran Kunder,Ranjit Unnikrishnan,Viswanathan Mohan

The Journal of the Association of Physicians of India(2020)

引用 1|浏览4
暂无评分
摘要
Fueled by perceptions regarding Indian dietary patterns and premixed insulin's claim to fame of providing dual fasting and post-prandial control, there was a greater inclination towards using premixed insulins in clinical practice until the last decade. However, the advent of insulin glargine 100 U/mL (Gla-100) opened up a new dimension in insulin therapy landscape in India. The data from the last 5 years reveal that Gla-100 has gained more traction among Indian clinical practitioners. Basis evidences that have emerged from various clinical studies, this present review elaborates on certain key issues which have helped Gla-100 carve its own niche and effected a progressive shift in insulin prescription pattern in India.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要